메뉴 건너뛰기
JAMA - Journal of the American Medical Association
Volumn 314, Issue 11, 2015, Pages 1113-1114
Immune checkpoint blockade in cancer therapy the 2015 Lasker-Debakey clinical medical research award
Author keywords

[No Author keywords available]
Indexed keywords

CARCINOGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IPILIMUMAB; RECOMBINANT INTERLEUKIN 2;
EID: 84942585297     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.11929     Document Type: Note
Times cited : (79)
References (8)
  • 1
    • 0026537347 scopus 로고
    • CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
    • Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature. 1992;356(6370):607-609.
    • (1992) Nature , vol.356 , Issue.6370 , pp. 607-609
    • Harding, F.A.1    McArthur, J.G.2    Gross, J.A.3    Raulet, D.H.4    Allison, J.P.5
  • 2
    • 0028484545 scopus 로고
    • CTLA-4 can function as a negative regulator of T cell activation
    • Walunas TL, Lenschow DJ, Bakker CY, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1994;1(5):405-413.
    • (1994) Immunity , vol.1 , Issue.5 , pp. 405-413
    • Walunas, T.L.1    Lenschow, D.J.2    Bakker, C.Y.3
  • 3
    • 0029120245 scopus 로고
    • CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
    • Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med. 1995;182(2):459-465.
    • (1995) J Exp Med , vol.182 , Issue.2 , pp. 459-465
    • Krummel, M.F.1    Allison, J.P.2
  • 4
    • 0029947568 scopus 로고    scopus 로고
    • Enhancement of antitumor immunity by CTLA-4 blockade
    • Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996;271(5256):1734-1736.
    • (1996) Science , vol.271 , Issue.5256 , pp. 1734-1736
    • Leach, D.R.1    Krummel, M.F.2    Allison, J.P.3
  • 5
    • 84927130807 scopus 로고    scopus 로고
    • Immune checkpoint targeting in cancer therapy
    • Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy. Cell. 2015;161(2):205-214.
    • (2015) Cell , vol.161 , Issue.2 , pp. 205-214
    • Sharma, P.1    Allison, J.P.2
  • 6
    • 84928917822 scopus 로고    scopus 로고
    • Pooled analysis of long-term survival data from phase II and phaseIIItrialsofipilimumabinunresectableormetastatic melanoma
    • Schadendorf D, Hodi FS, Robert C, et al. Pooled analysis of long-term survival data from phase II and phaseIIItrialsofipilimumabinunresectableormetastatic melanoma. J Clin Oncol. 2015;33(17):1889-1894.
    • (2015) J Clin Oncol , vol.33 , Issue.17 , pp. 1889-1894
    • Schadendorf, D.1    Hodi, F.S.2    Robert, C.3
  • 7
    • 77749279776 scopus 로고    scopus 로고
    • PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
    • Curran MA, Montalvo W, Yagita H, Allison JP. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci U S A. 2010;107(9):4275-4280.
    • (2010) Proc Natl Acad Sci U S a , vol.107 , Issue.9 , pp. 4275-4280
    • Curran, M.A.1    Montalvo, W.2    Yagita, H.3    Allison, J.P.4
  • 8
    • 84936147067 scopus 로고    scopus 로고
    • Combined nivolumabandipilimumabormonotherapyinuntreated melanoma
    • Larkin J, Chiarion-Sileni V, Gonzalez R, et al.Combined nivolumabandipilimumabormonotherapyinuntreated melanoma.N Engl J Med. 2015;373(1):23-34.
    • (2015) N Engl J Med , vol.373 , Issue.1 , pp. 23-34
    • Larkin, J.1    Chiarion-Sileni, V.2    Gonzalez, R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.